Using ketamine to help prevent chronic pain after surgery
Optimizing the use of ketamine to reduce chronic postsurgical pain
This study is looking at how ketamine can help reduce pain and anxiety during and after breast surgery to prevent long-lasting pain afterwards, and it's designed for patients having mastectomy or breast-conserving surgery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10909245 on NIH RePORTER |
What this research studies
This research investigates how ketamine can be used during and after surgery to prevent chronic postsurgical pain (CPSP), particularly in patients undergoing mastectomy or breast-conserving surgery. The study aims to assess the effectiveness of ketamine in reducing acute pain, anxiety, and depression, which are known risk factors for developing CPSP. By administering ketamine perioperatively, the researchers hope to enhance the body's natural pain control mechanisms and improve overall patient outcomes. The study is part of a larger initiative focused on improving pain management strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients scheduled for mastectomy or breast-conserving surgery who are at risk for developing chronic postsurgical pain.
Not a fit: Patients who are not undergoing surgery or those who do not experience significant postoperative pain may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of chronic pain in postoperative patients, leading to less reliance on opioids.
How similar studies have performed: There is strong clinical evidence supporting the use of ketamine for managing postsurgical pain, indicating that this approach has shown promise in previous studies.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Wang, Jing — New York University School of Medicine
- Study coordinator: Wang, Jing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.